Test Price
2,800 AED✅ Home Collection Available
GNMT Gene Glycine N‑Methyltransferase Deficiency Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
● Diagnostic Accuracy: 99.9% analytical sensitivity for GNMT variants via ISO‑accredited NGS, confirmed by orthogonal validation.
● Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM for whole blood, extracted DNA, or FTA cards.
● Clinical Guidance: Telephonic post‑test consultation with DHA‑licensed experts to interpret results within UAE healthcare context.
● Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The GNMT Gene NGS Test screens the entire coding region of the glycine N‑methyltransferase gene for pathogenic variants linked to hepatorenal and endocrine dysfunction. It delivers a definitive molecular diagnosis using next‑generation sequencing with 100% coverage of clinically significant exons and intronic boundaries.
| Feature | Our Test (GNMT NGS) | Closest Alternative (Biochemical Assay) |
|---|---|---|
| Methodology | Targeted NGS (Illumina® platform) – single‑gene full‑exon analysis | Serum methionine/S‑adenosylmethionine levels |
| Diagnostic Yield | >99.9% analytical sensitivity for point mutations and small indels | Indirect; may miss heterozygous or atypical presentations |
| Turnaround Time | 3–4 weeks from sample receipt | 5–10 working days |
Physician Insight & Safety Protocols
“As a clinical geneticist, I view each GNMT NGS result as one piece of a larger diagnostic mosaic. This assay provides a precise molecular anchor, but it must be integrated with full biochemical profiles, hepatic imaging, and longitudinal clinical assessment. We collaborate directly with your managing hepatologist or genetic counsellor to build a comprehensive care pathway. A DNA finding alone should never drive therapeutic changes.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medication Advisory
Do not discontinue or modify any prescribed therapy — including methionine‑restricted diet supplements, liver support agents, or anticonvulsants — without direct supervision from your treating physician. Abrupt changes may precipitate metabolic decompensation. Always consult your specialist before adjusting any regimen based on genetic information.
Exclusion Criteria & Emergency Red Flags
- Collection Exclusion: Active systemic infection, coagulopathy (INR >2.5), or platelet count <50,000/µL — risk of haematoma. Delay home draw until stabilised.
- Neonatal/Pediatric Alert: Parents or legal guardians must accompany minors; test request must comply with Federal Decree-Law No. 4 of 2016 on Medical Liability for patients under 18.
- ER Red Flags (seek immediate care): Sudden onset of severe vomiting, altered consciousness, seizures, or hypoglycaemia in a patient with suspected metabolic disorder.
- Specimen Integrity: Samples haemolysed, clotted, or incorrectly stored will be rejected automatically; recollection at no extra charge.
Patient FAQ & Clinical Guidance
1. What exactly does the GNMT NGS test detect, and why is it ordered?
It identifies pathogenic DNA variants in the entire GNMT gene that cause glycine N‑methyltransferase deficiency, a condition linked to liver disease, kidney dysfunction, and abnormal methionine metabolism. Physicians order it when biochemical markers suggest a glycine metabolism disorder or to clarify a family history of hepatorenal disease.
2. How is the sample collected, and what preparation is required?
A certified phlebotomist visits your home for a venous blood draw, or we accept pre‑extracted DNA or FTA card drop‑off. No fasting or medication hold is required unless your doctor specifically advises otherwise; bring a detailed clinical history and any previous genetic counselling pedigree chart.
3. Will my insurance cover this test and how do I confirm?
Coverage varies by plan; we offer free pre‑approval verification via WhatsApp at +971 54 548 8731. Send a copy of your insurance card and Emirates ID; our team responds within two working hours with a confirmation and any co‑payment details.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are encrypted, access‑controlled, and processed solely for diagnostic purposes. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your privacy and data sovereignty are protected under UAE law.
Clinical & Logistical Metadata
| Test Name | GNMT Gene Glycine N‑Methyltransferase Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card – VIP mobile phlebotomy & temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM |
| Methodology Used | Targeted next‑generation sequencing (NGS) – Illumina® platform, full‑exon coverage |
| ICD-10-CM Code | E72.29 |
| LOINC Code | 92849-0 |
| DHA Facility License & Laboratory Address | License Number 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians